Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 16 July 2020
      Key Trade Data Points on the EU27 Pharmaceutical Supply Chain
 
 
In 2019, 86.2% of EU27 imports of Human Medicinal Products came from Europe.
 
In this study, ECIPE has used Eurostat (2019) data to look at the imports and exports of the EU27 in value (Euro) and volume (kg) terms for the pharmaceutical sector. Statistics are reported for the overall pharmaceutical products, human medicinal products, vaccines, and antibiotics.

The main findings are that the EU27 is a strong exporter of pharmaceutical products, and in terms of imports is resilient because most come from the EU itself. China and India are not large exporters to the EU, except for China's share in APIs in volume terms (kg). But even in the latter case, total imports amount to 22.5% of all EU27 imports.
Read more →
 
 
      #WeWontRest in the fight against AMR
Last week, more than 20 leading biopharmaceutical companies announced the launch of the AMR Action Fund, a ground-breaking partnership that aims to bring 2-4 new antibiotics to patients by 2030.
 
 
  10 July 2020 IMI Impact: tackling antimicrobial resistance together

The Innovative Medicines Initiative is delivering fresh hope in the search for new antibiotics

Read more →
 
 
 
  16 July 2020 Europe’s COVID-19 response points the way to fighting AMR

Antimicrobial resistance: Perspectives from a pharmaceutical SME

Read more →
 
 
 
      Blogs
 
  16 July 2020 Europe’s cancer battle has momentum – let’s build on it

EU institutions are stepping up the fight against cancer. The new ‘Challenge Cancer’ Intergroup can be a platform for...

Read more →
 
 
 
  16 July 2020 How biotech SMEs adapted to COVID-19: An interview with Minoryx Therapeutics

As the pandemic threatened to disrupt key clinical trials, a small company responded swiftly to protect patients and...

Read more →
 
 
 
  15 July 2020 EU strategic resilience in pharmaceuticals: global value chains and innovation

One concept that has been much discussed recently as a result of the COVID-19 crisis has been the need for the region...

Read more →
 
 
 
      Events
 
 
10 SEP 2020
  Patient Engagement Open Forum Series of virtual events

The Patient Engagement Open Forum 2020 will go virtual with a series of virtual events from June 25th until the end...

Learn more →
 
 
 
26 OCT 2020
  NEW DATES - EU Health Summit 2020 Virtual event

The EU Health Coalition is delighted to announce the second edition of the EU Health Summit.

Learn more →
 
 
      Our latest publications
EFPIA code report 2019 16 July 2020 (Publications)
This annual Code Report summarises the work and activities that have taken place in connection with the implementation,...
Read more →
2020: The Pharmaceutical Industry in Figures 30 June 2020 (Publications)
Our annual statistics leaflet
Read more →
 
      What we are reading
Reviewing orphan drugs law: A tough equation 06 July 2020  (Euractiv) Read more →
European Parliament keen to play key role in boosting actions to tackle AMR 14 July 2020  (The Parliament Magazine) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe